Blood test checks for bipolar, lithium treatment potential
New research can save patients months of adjustment to the right medicine, Israeli-led study determines.
New research can save patients months of adjustment to the right medicine, Israeli-led study determines.
Suicidal bipolar depression accounts for 40% of people who try to harm themselves, yet there’s never been an FDA-approved drug for this indication.
Combining antidepressant therapy with mood stabilizers can help prevent re-hospitalization from bipolar depression, Israeli researchers say.
The small Israeli pharma company NeuroRx is testing a novel compound of two existing drugs to quash suicidal feelings.